ÂÜÀòÂÒÂ×

Stefanos Theoharis is an accomplished leader in the biopharmaceutical industry with extensive experience in executive and corporate development roles. Currently serving as Chief Executive Officer at OneChain Immunotherapeutics and Venture Partner at Deep Science Ventures, Theoharis specializes in building innovative companies focused on cell and gene therapies, immunotherapy, and oncology. Previous roles include Managing Director at Venture Advanced Therapies, Chief Business Officer at BONE THERAPEUTICS S.A., and Senior Vice President of Corporate Development at Cell Medica. With a strong academic background, including a PhD in Cell & Gene Therapy from Imperial College London, Theoharis has a proven track record in strategy generation, licensing, due diligence, and partnership development across various organizations.